PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice
Mohamed A. Ghonim(St. Jude Children's Research Hospital), A. Hamid Boulares(Louisiana State University Health Sciences Center New Orleans)
Cited by 38
Related Papers
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
|British Journal of Pharmacology|2017|210
PDZK1 Is a Novel Factor in Breast Cancer That Is Indirectly Regulated by Estrogen through IGF-1R and Promotes Estrogen-Mediated Growth
|Molecular Medicine|2013|101
PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function
|Journal of Translational Medicine|2015|48